Literature DB >> 17720528

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17720528     DOI： 10.1053/j.ajkd.2007.06.008

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  175 in total

1.  The effect of a multidisciplinary care clinic on the outcomes in pediatric chronic kidney disease.

Authors:  Salma Ajarmeh; Lee Er; Genevieve Brin; Ognjenka Djurdjev; Janis M Dionne
Journal:  Pediatr Nephrol       Date:  2012-06-05       Impact factor: 3.714

2.  Should erythropoiesis-stimulating agents be used in predialysis patients?

Authors:  Rene Breault
Journal:  Can J Hosp Pharm       Date:  2011-03

3.  The target hemoglobin in non-dialysis CKD: still a matter for debate?

Authors:  Satoru Kuriyama
Journal:  Clin Exp Nephrol       Date:  2010-03-19       Impact factor: 2.801

4.  Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients.

Authors:  David A Goodkin; Douglas S Fuller; Bruce M Robinson; Christian Combe; Richard Fluck; David Mendelssohn; Tadao Akizawa; Ronald L Pisoni; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 10.121

5.  Complete correction of anemia by erythropoiesis-stimulating agents is associated with insulin resistance in hemodialysis patients.

Authors:  Gianni Biolo; Gianfranco Guarnieri; Rocco Barazzoni; Giovanni Panzetta
Journal:  Clin Exp Med       Date:  2010-11-16       Impact factor: 3.984

6.  Association of ESA hypo-responsiveness and haemoglobin variability with mortality in haemodialysis patients.

Authors:  Alexander Kainz; Bernd Mayer; Reinhard Kramar; Rainer Oberbauer
Journal:  Nephrol Dial Transplant       Date:  2010-05-26       Impact factor: 5.992

Review 7.  [The role of platelets in atherosclerosis, diabetes mellitus, and chronic kidney disease. An attempt at explaining the TREAT study results].

Authors:  Norbert Maurin
Journal:  Med Klin (Munich)       Date:  2010-05-26

8.  Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis.

Authors:  Raja Zabaneh; Simon D Roger; Mohamed El-Shahawy; Michael Roppolo; Grant Runyan; Janet O'Neil; Ping Qiu
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

9.  Anemia in children following renal transplantation-results from the ESPN/ERA-EDTA Registry.

Authors:  Leah A Krischock; Karlijn J van Stralen; Enrico Verrina; E Jane Tizard; Marjolein Bonthuis; György Reusz; Farida K Hussain; Augustina Jankauskiene; Gregor Novljan; Brankica Spasojević-Dimitrijeva; Ludmila Podracka; Vera Zaller; Kitty J Jager; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2015-09-18       Impact factor: 3.714

10.  Effect of erythropoiesis-stimulating agents on hemoglobin level, fatigue and hospitalization rate in renal palliative care patients.

Authors:  Kwok-Ying Chan; Cho-Wing Li; Hilda Wong; Terence Yip; Mau-Kwong Sham; Hon-Wai Cheng; Kay-Cheong Teo; Wang-Chun Kwok; Tak-Mao Chan
Journal:  Int Urol Nephrol       Date:  2014-02-14       Impact factor: 2.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.